Faculty of Life Sciences & Medicine

Located across four central London campuses, the Faculty of Life Sciences & Medicine is one of the largest and most successful centres for research and education in the UK.

Through connections with London's world-leading research institutes, teaching hospitals and collaborations with higher education institutions, the Faculty provides an unrivalled learning experience and research infrastructure for its staff and students.

Faculty collaborations with London include:

• King's Health Partners bring together King's with three leading NHS Foundation Trusts – Guy's and St Thomas’ now incorporating Royal Brompton and Harefield, King’s College Hospital and South London and Maudsley – to translate cutting-edge research and existing best practice into excellent patient care.
• The London Institute for Healthcare Engineering, a joint initiative led by King’s School of Biomedical Engineering & Imaging Sciences and Guy's and St Thomas' NHS Foundation Trust, to ensure that research in healthcare engineering is translated rapidly into new products and technologies that will benefit patients across the capital and around the world.
• The London Medical Imaging and AI Centre for Value-Based Healthcare, led by King’s and Guy's and Thomas’ NHS Foundation Trust, alongside 10 NHS Trusts, four Universities, a number of multi-national industry partners, will use advanced imaging and AI technologies to optimise patient care and hospital operations in London and beyond. 
• London Advanced Therapies (LAT), funded by Research England, and led by King’s, Imperial College London and University College London, aims to catalyse London’s advanced therapies capabilities and outputs by fostering collaborative work, facilitating commercial partnerships and creating a microclimate for innovation.
• The Cancer Research UK City of London (CoL) Centre is a world-class hub for cancer biotherapeutics that brings together researchers from King’s, UCL, Barts/Queen Mary University of London and The Francis Crick Institute to generate novel innovative biological therapies, diagnostics and stratification strategies, in addition to providing a clinical and translational pipeline for cancer discovery science.